Compare Etsy Inc (ETSY) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Etsy Inc vs Eli Lilly And Co — how do they compare? Etsy Inc trades at $85.6 (market cap $8.14B), while Eli Lilly And Co trades at $1,173.2 (market cap $1.03T). The key difference: Eli Lilly And Co is far larger — about 126.5× Etsy Inc's market cap, and Eli Lilly And Co pays a 0.6% dividend while Etsy Inc pays none. Which is the better fit depends on your goals.
| ETSY | LLY | |
|---|---|---|
Market Cap | $8.14B | $1.03T |
Sector | Consumer Cyclical | Health |
52-Week High | $85.74 | $1.24K |
52-Week Low | $44.05 | $625.65 |
Enterprise Value | $9.79B | $1.07T |
Dividend Yield | — | 0.6% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Etsy stock trades at $83.06, up 3.14% recently and showing strong technical momentum with bullish moving average signals. The company has beaten earnings expectations for three consecutive quarters, with Q1 2026 EPS of $0.89 surpassing the $0.62 estimate. However, valuation metrics appear elevated with a P/E of 32.85 and P/B of 52.12, while the company maintains strong gross margins of 71.55% and positive operating cash flow of $693.41M in 2025.
The outlook is mixed with improving buyer momentum and AI-driven engagement tools supporting growth, but active buyer declines and high debt levels present risks. Analyst sentiment leans positive with 22 buy ratings versus 3 sells, though the consensus price target of $72.38 suggests 13% downside from current levels. The Depop divestiture to eBay removes a distraction, allowing focus on core marketplace improvements.
LLY trades at $1,154.27, down 2.6% today, amid a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q1 2026 EPS of $8.55 surpassing the $6.97 forecast. Revenue surged to $65.18B in 2025, driving a net income margin of 34.99%. Recent news includes the acquisition of AtaiBeckley for $2.8 billion, expanding its neuroscience pipeline.
Outlook remains positive with a consensus price target of $1,380, though high valuation multiples (P/E 41.09) and competitive pressures in obesity drugs present risks. Analyst sentiment is strongly bullish (73% buy ratings), supporting further upside if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
